Dr. Jonathan Wang
Molecular Neurobiology
Waterstone Pharmaceuticals
Taiwan
Biography
Dr. Jonathan Wang is a Senior Managing Director, Asia at OrbiMed. With over 20 years of healthcare and life sciences experience, spanning investment, finance and research, he has co-founded OrbiMed Asia. Previously, he was a Partner at Legend Capital and General Manager, Greater China at Burrill & Company. He also worked for WI Harper Group, where he was a Managing Director overseeing the firm’s life sciences activities worldwide, and Walden International. He was a Board Director at ForteBio, Inc. (acquired by Pall Corporation) and is Chairman at Bonovo Orthopedics, Inc. He is a Board Director at EA, Inc. (formerly Chairman), Response Biomedical Corporation (TSE: RBM) and Waterstone Pharmaceuticals, Inc. He is a co-founder and former Chairman of The BayHelix Group, a premier organization of Chinese life sciences business leaders. He holds a Ph.D. in Molecular Neurobiology from Columbia University, where he obtained scientific training under the supervision of Dr. Eric Kandel, a Nobel Laureate. He was rewarded the Howard Hughes Medical Institute (HHMI) Research Fellowship at Columbia. He also earned an MBA from Stanford University.
Research Interest
Molecular Neurobiology
